Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Moderna, Inc.
  6. News
  7. Summary
    MRNA   US60770K1079

MODERNA, INC.

(MRNA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Moderna : U.S. administers 344.93 mln doses of COVID-19 vaccines - CDC

07/30/2021 | 02:42pm EDT

July 30 (Reuters) - The United States had administered 344,928,514 doses of COVID-19 vaccines in the country and distributed 399,090,105 doses as of Friday morning, the U.S. Centers for Disease Control and Prevention said.

The figures were up from the 344,071,595 vaccine doses the CDC said had gone into arms by July 29, out of 397,464,625 doses delivered.

The agency said 190,509,183 people had received at least one dose, while 164,184,080 people were fully vaccinated as of Friday.

The CDC tally includes two-dose vaccines from Moderna and Pfizer/BioNTech , as well as Johnson & Johnson's one-shot vaccine as of 6:00 a.m. ET on Friday. (Reporting by Manojna Maddipatla in Bengaluru; Editing by Shinjini Ganguli)


© Reuters 2021
All news about MODERNA, INC.
09/16Pfizer-BioNTech, Moderna's Booster COVID-19 Shots Enters Real-Time Review in ..
MT
09/16UK Study to Mix Three COVID-19 Vaccine Doses in Adolescents
MT
09/16Healthcare Shares Slip as Investors Mull Delta Spread -- Healthcare Roundup
DJ
09/16MODERNA : U.S. administers 383 mln doses of COVID-19 vaccines - CDC
RE
09/16GOODBYE PFIZER, HELLO COMIRNATY : top COVID-19 vaccines renamed in Canada
AQ
09/16MODERNA : Pfizer, Biontech Receive Approval From Health Canada for COVID-19 Vacc..
MT
09/16MODERNA : Announces Health Canada Approves its COVID-19 Vaccine
BU
09/16PFIZER : FDA Sees Current COVID-19 Vaccine Protocol as Still Effective Ahead of ..
MT
09/16MODERNA : Buy rating from Goldman Sachs
MD
09/16WALL STREET STOCK EXCHANGE : US economy shows resilience, while China falters
More news
Analyst Recommendations on MODERNA, INC.
More recommendations
Financials (USD)
Sales 2021 20 348 M - -
Net income 2021 12 529 M - -
Net cash 2021 12 947 M - -
P/E ratio 2021 14,8x
Yield 2021 -
Capitalization 178 B 178 B -
EV / Sales 2021 8,11x
EV / Sales 2022 7,50x
Nbr of Employees 1 300
Free-Float 90,3%
Chart MODERNA, INC.
Duration : Period :
Moderna, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MODERNA, INC.
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 16
Last Close Price 440,65 $
Average target price 306,23 $
Spread / Average Target -30,5%
EPS Revisions
Managers and Directors
Stéphane Bancel Chief Executive Officer & Director
Stephen Hoge President
David W. Meline Chief Financial Officer
Noubar B. Afeyan Chairman
Juan Andres Chief Technical Operations & Quality Officer
Sector and Competitors
1st jan.Capi. (M$)
MODERNA, INC.321.80%177 867
LONZA GROUP AG34.92%61 973
IQVIA HOLDINGS INC.43.91%49 541
CELLTRION, INC.-25.63%31 848
SEAGEN INC.-12.32%27 670
PHARMARON BEIJING CO., LTD.74.42%24 684